Clinical relevance of the ESKAPE pathogens

@article{Pendleton2013ClinicalRO,
  title={Clinical relevance of the ESKAPE pathogens},
  author={Jack Norman Pendleton and Sean P. Gorman and Brendan F. Gilmore},
  journal={Expert Review of Anti-infective Therapy},
  year={2013},
  volume={11},
  pages={297 - 308}
}
In recent years, the Infectious Diseases Society of America has highlighted a faction of antibiotic-resistant bacteria (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.) – acronymically dubbed ‘the ESKAPE pathogens’ – capable of ‘escaping’ the biocidal action of antibiotics and mutually representing new paradigms in pathogenesis, transmission and resistance. This review aims to consolidate clinically… 

Update on the main MDR pathogens: prevalence and treatment options.

  • S. EspositoG. De Simone
  • Medicine, Biology
    Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive
  • 2017
This review represents the rise of MDR among the ESKAPE pathogens over the decades and reports studies from each continent showing the current prevalence and burden of such infections worldwide.

Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review

The objective of this review is to describe the alternative therapies reported to treat ESKAPE infections, their advantages and limitations, potential application in vivo, and status in clinical trials.

Light and Shade of New Antibiotics

The ability to ‘escape’ from commonly used antibacterial treatment and the microorganisms that are mainly involved in the resistance process are the so-called ESKAPE pathogens.

Klebsiella pneumoniae: microbiological characterization, antimicrobial resistance, and virulence

In this literature review, literature data on the molecular resistant mechanisms, virulence factors and infectious diseases caused by Klebsiella pneumoniae is discussed.

New Therapeutic Methods to Treat Infections Caused by The ESKAPE Pathogens

Three new antimicrobial therapies have been developed that may provide new strategies for the therapeutic intervention of extremely antibiotic resistant bacterial species.

Opportunisitic Pathogens of Humans

This chapter highlights the populations at greatest risk for OI, as well as the major bacterial and fungal OPs that threaten human health and burden modern healthcare systems.

Foodborne ESKAPE Biofilms and Antimicrobial Resistance: lessons Learned from Clinical Isolates

The review provides a comprehensive overview of the signaling mechanisms that prevail in the ESKAPE pathogens for adhesion to abiotic and biotic surfaces and molecular mechanisms associated with poly-microbial biofilm-assisted AMR in ESKape.

Understanding, preventing and eradicating Klebsiella pneumoniae biofilms.

This work focused on Klebsiella pneumoniae, an opportunistic bacterium that causes different types of infections, including in the bloodstream, meninges, lungs, urinary system and at surgical sites, and highlights aspects involved in the formation and maintenance of K. pneumoniae biofilms.

ANTIMICROBIAL RESISTANCE OF ESKAPE-PATHOGENS IN CULTURE-POSITIVE PNEUMONIA

ESKAPE pathogens are commonly identified in HCAP and HAP/VAP and an alarming frequency of highly resistant pathogens in hospital-acquired and ventilator-associated pneumonia was noticed.

Characterisation of ESKAPE Pathogens with Special Reference to Multidrug Resistance and Biofilm Production in a Nepalese Hospital

A high percentage of drug resistance and biofilm production was noted; hence antimicrobial resistance surveillance targeting ESKAPE pathogens should be incorporated in the infection control policy in Nepal.
...

References

SHOWING 1-10 OF 116 REFERENCES

Linezolid resistance in clinical isolates of Staphylococcus aureus.

A second clinical infection due to a resistant MRSA was reported, but unlike the earlier case this was shown to have developed from a susceptible isolate during treatment, and linezolid susceptibility was determined.

Klebsiella spp. as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors

Klebsiella pathogenicity factors such as capsules or lipopolysaccharides are presently considered to be promising candidates for vaccination efforts that may serve as immunological infection control measures.

Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia.

We describe a patient who developed daptomycin-resistant, methicillin-resistant Staphylococcus aureus (MRSA) during an episode of presumed septic thrombophlebitis of the portal vein. Although

Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii.

This review is focused on the current knowledge of porins and efflux pump(s) in this microorganism and the ability to acquire multidrug resistance.

Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?

  • D. Livermore
  • Biology
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2002
Pseudomonas aeruginosa carries multiresistance plasmids less often than does Klebsiella pneumoniae, develops mutational resistance to cephalosporins less readily than Enterobacter species, and has

Development of Daptomycin Resistance In Vivo in Methicillin-Resistant Staphylococcus aureus

Daptomycin at high concentration retained bactericidal activity against resistant isolates and resistance in patients with osteomyelitis due to methicillin-resistant S. aureus.

Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE.

  • L. Rice
  • Medicine
    The Journal of infectious diseases
  • 2008
The research agenda of the National Institute of Allergy and Infectious Diseases (NIAID) for antimicrobial resistance is detailed, indicating that NIAID funding of antimicrobial research has grown considerably over the past decade, now totaling more than $800 million annually.

Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06.

BACKGROUND Enterobacteriaceae are common agents of bacteraemia, with Escherichia coli accounting for 20% of the cases. Reflecting this importance, members of the family constitute 4 of the 12
...